The Study of Efficacy and Safety of REGPARA Drug in Dialysis Patients Have High Blood Levels of Parathyroid
NCT02056730
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Hyperparathyroidism, Secondary
Interventions
DRUG:
calcium sensing receptor agonist
Sponsor
Chulalongkorn University